United States
United States media releases from federal and state governments and company newsrooms.
Latest releases
-
California Governor Gavin Newsom sent a letter to the chief judges of the state's four federal district courts warning of potential election interference by the Trump administration ahead of Tuesday's election. The letter raises concerns that federal agents could seek search warrants to seize ballots or election materials before results are certified, and shares a UC Berkeley Edley Center resource for assessing such warrant applications.
-
The U.S. G20 presidency released a Chair's Statement after G20 foreign ministers met in Atlanta, Georgia, on October 30 and 31, 2026. Ministers discussed energy security, supply chain resilience including critical minerals and fertilizer, and geopolitical tensions including the Straits of Hormuz and the Bab al-Mandab. The statement noted $2 billion raised in September to fight Ebola and looked ahead to the Leaders' Summit in Miami and the United Kingdom's 2027 presidency.
-
Foreign ministers of the United States, Australia, India and Japan met in Atlanta, Georgia, on October 31, 2026, and issued a Quad joint statement on economic prosperity and security in the Indo-Pacific. They pledged over $85 million in technical and financial assistance to support access to trusted Super Intelligence, condemned criminal groups running online scam operations, and reported progress on critical minerals, fuel security, ports in Fiji, maritime surveillance and undersea cables.
-
New York Governor Kathy Hochul announced more than $249 million in grants for 181 water quality projects across the state. More than $246 million supports 139 projects through the Department of Environmental Conservation's Water Quality Improvement Project program, and $2.9 million funds 42 planning projects. More than $206 million will benefit environmental justice communities, and about $122 million targets watersheds affected by harmful algal blooms.
-
The U.S. Department of Health and Human Services said the FDA approved updated labeling for three more menopausal hormone therapy products, estradiol transdermal patches, removing boxed-warning statements on cardiovascular disease, breast cancer and probable dementia. The action follows similar changes for six products in February 2026. FDA said 29 companies have submitted proposed labeling changes and patch market output has doubled in 12 months amid rising demand.